Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Synthesis and biological evaluation reported for quinolonyl-carbacephems

Oct. 7, 1997

Abbott presents new ketolides based on TE-802

Oct. 7, 1997

P&G presents new quinolonyl-lactams

Oct. 7, 1997

Abbott describes synthesis and evaluation of novel erythromycin derivatives

Oct. 7, 1997

Abbott prepares and evaluates tetracyclic ketolides as antibacterials

Oct. 6, 1997

New antifungal antibiotic with sphingosine-like lipid moiety

Oct. 6, 1997

Korean research institute synthesizes potent DNA gyrase inhibitors

Oct. 6, 1997

GS-4104 (Ro-64-0796): safety and pharmacokinetics in humans

Oct. 6, 1997

Safety and efficacy data for INVICORP reported at impotence meeting

Oct. 6, 1997

MOMP DNA immunization for chlamydial infections

Oct. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...